Sinsin Pharmaceutical Co. Ltd

002800 · KQ · Healthcare / Drug Manufacturers - Specialty & Generic

3,890.00KRW+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close3,890.00

Open3,930.00

Day Range3,885.00 – 4,000.00

52-Week Range3,900.00 – 6,917.44

Volume22.78K

Market Cap66.83B

P/E (TTM)0.00

Forward P/E0.00

Dividend Yield1.81%

Beta0.22

50-Day Avg4,429.80

200-Day Avg5,159.00

About

Sinsin Pharmaceutical Co., Ltd manufactures and sells pharmaceutical products in South Korea. It offers various medicinal products, such as plaster, aerosol, topical liquid, emollient, hygiene, and ointment products, as well as adhesive bandages, mosquito repellents, anti-perspirants, cooling sheets, bruise treatment creams, and other products. The company also develops transdermal drug delivery system, and bag on valve inhaler and aerosol solubilzation system. In addition, it exports its products to approximately 30 countries worldwide. The company was founded in 1959 and is headquartered in Sejong, South Korea.

Company Details

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. Ki Lee Byoung
Employees356
Headquarters9, Sojeongsandandong-ro, Sejong, South Korea, 30002, Korea
Websitehttps://www.sinsin.com

Leadership

Mr. Ki Lee ByoungChairman, President & CEO · b. 1957

Financials

Income Statement

Currency: KRW	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	51.61B	58.07B	61.73B	63.72B	67.85B	67.13B	74.01B	91.93B	102.59B	106.39B	113.78B
Growth (%)	-	+12.51%	+6.31%	+3.22%	+6.49%	-1.07%	+10.25%	+24.21%	+11.60%	+3.71%	+6.95%
Cost of Revenue	32.34B	37.03B	40.04B	41.52B	44.28B	48.62B	52.23B	61.63B	69.18B	70.17B	70.67B
Gross Profit	19.28B	21.04B	21.69B	22.20B	23.58B	18.51B	21.77B	30.30B	33.41B	36.22B	43.11B
Gross Margin	37.35%	36.23%	35.14%	34.83%	34.75%	27.58%	29.42%	32.96%	32.57%	34.04%	37.89%
Operating Expense	13.95B	15.51B	17.21B	19.16B	21.55B	22.68B	23.13B	24.87B	27.40B	29.33B	32.32B
Operating Income	5.32B	5.53B	4.48B	3.04B	2.03B	-4.17B	-1.36B	5.43B	6.00B	6.89B	10.79B
Operating Margin	10.31%	9.52%	7.26%	4.76%	2.99%	-6.21%	-1.84%	5.90%	5.85%	6.48%	9.48%
EBITDA	-	-	-	-	-	-	-	9.29B	9.87B	11.36B	15.60B
EBITDA Margin	-	-	-	-	-	-	-	10.10%	9.62%	10.68%	13.71%
Net Income	3.89B	4.44B	3.60B	2.90B	2.14B	362.66M	-1.48B	4.41B	4.68B	4.89B	9.29B
Net Income Margin	7.53%	7.65%	5.84%	4.54%	3.15%	0.54%	-1.99%	4.80%	4.56%	4.59%	8.17%
R&D	-	74.98M	138.94M	160.15M	562.74M	785.21M	709.07M	89.90M	488.03M	474.50M	898.01M
R&D as % of Total Revenue	-	0.13%	0.23%	0.25%	0.83%	1.17%	0.96%	0.10%	0.48%	0.45%	0.79%
Interest Expense	0	0	0	0	256.56M	893.62M	963.24M	1.48B	1.94B	1.96B	1.64B
Interest Expense % of Total Revenue	0.00%	0.00%	0.00%	0.00%	0.38%	1.33%	1.30%	1.61%	1.89%	1.84%	1.44%

Balance Sheet

Currency: KRW	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	68.81B	78.85B	107.92B	129.24B	118.13B	114.31B	121.21B	124.41B	129.48B	137.50B
Total Liabilities	34.38B	26.74B	53.38B	72.87B	61.94B	59.38B	61.52B	62.32B	63.61B	62.98B
Total Equity	34.43B	52.12B	54.54B	56.36B	56.20B	54.93B	59.70B	62.30B	65.87B	74.83B
Cash	648.78M	7.28B	1.89B	1.13B	2.50B	799.33M	2.24B	346.46M	539.85M	3.88B
Total Debt	-	6.24B	27.45B	48.28B	36.90B	-	-	-	-	-
Net Debt	-	-	-	-	42.47B	45.19B	41.05B	44.02B	44.78B	39.64B

Cash Flow

Currency: KRW	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	5.24B	2.79B	4.57B	774.24M	-4.51B	1.87B	23.18M	5.46B	3.93B	5.94B	8.58B
Investing Cash Flow	-1.87B	-5.59B	-3.60B	-25.67B	-20.56B	8.63B	-2.65B	-1.14B	-6.05B	-5.56B	-
Financing Cash Flow	-3.39B	3.07B	5.67B	19.51B	24.32B	-9.09B	924.86M	-2.82B	225.54M	-208.41M	-
Capital Expenditure	5.22B	7.43B	3.57B	25.44B	20.50B	11.97B	2.68B	907.13M	5.03B	1.51B	1.61B
Free Cash Flow	-	-	-	-	-	-10.29B	-2.66B	4.42B	-1.10B	4.43B	6.97B
Dividends Paid	-	242.00M	401.98M	500.63M	500.63M	424.77M	0	-	758.52M	910.23M	910.23M
FCF to OCF	-	-	-	-	-	-551.59%	-11469.53%	80.92%	-27.92%	74.52%	81.22%
Dividend Paid to FCF	-	-	-	-	-	-4.13%	0.00%	-	-69.12%	20.55%	13.06%

Earnings

Report Date	May 15, 2017	Aug 23, 2017	Nov 13, 2017	Mar 15, 2018	Apr 27, 2018	Aug 14, 2018	Nov 14, 2018	Dec 31, 2018	May 14, 2019	Aug 14, 2019	Nov 14, 2019	Mar 19, 2020	May 12, 2020	Aug 14, 2020	Nov 16, 2020	Jan 25, 2021	Mar 31, 2021	Jun 30, 2021	Sep 30, 2021	Dec 31, 2021	Mar 31, 2022	Jun 30, 2022	Sep 30, 2022	Dec 31, 2022	Mar 31, 2023	Jun 30, 2023	Sep 30, 2023	Dec 31, 2023	Mar 31, 2024	Jun 30, 2024	Sep 30, 2024	Dec 31, 2024	Mar 31, 2025	Jun 30, 2025	Sep 30, 2025	Dec 31, 2025	Mar 31, 2026	Jun 30, 2026
EPS Estimate	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Actual	69.80	90.54	55.00	29.49	49.05	77.12	28.36	36.37	55.79	49.01	47.15	-11.05	52.00	-71.00	141.00	-98.86	-53.23	-21.51	-14.15	-8.39	30.77	160.13	98.76	1.33	48.47	197.41	75.74	-13.14	24.37	179.91	71.48	46.48	66.24	90.27	225.55	230.44	188.78	242.88
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	After-hours	After-hours	Pre-market	After-hours	Pre-market	Pre-market	Pre-market	-	After-hours	Pre-market	-	After-hours	Pre-market	Pre-market	Pre-market	After-hours	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Key Statistics & Ratios

Market Cap66.83B

Enterprise Value104.22B

Trailing P/E0.00

Forward P/E0.00

Price / Sales0.54

Price / Book0.85

Revenue (TTM)123.05B

Gross Profit (TTM)48.05B

EBITDA18.61B

Profit Margin10.94%

Operating Margin11.96%

Return on Equity18.28%

Return on Assets6.58%

Shares Outstanding15.17M

Shares Float7.30M

Beta0.22

Dividend Yield1.81%

Dividend Rate80.00

Payout Ratio9.01%

Dividends

20251×

80.00Dec 29, 2025

20241×

60.00Dec 27, 2024

20231×

60.00Dec 27, 2023

20221×

50.00Dec 28, 2022

20201×

28.00Dec 29, 2020

20191×

28.00Dec 27, 2019

20181×

33.00Dec 27, 2018

20171×

33.00Dec 27, 2017